Diammonium glycyrrhizinate, commonly derived from licorice root, is a compound with a diverse range of pharmacological properties. It is most notable for its anti-inflammatory, antiviral, and hepatoprotective effects. To appreciate its mechanism of action, it is essential to delve into its biochemical interactions and physiological impacts.
Firstly, diammonium glycyrrhizinate exhibits its anti-inflammatory properties by interacting with the
glucocorticoid receptor. This interaction mimics the effects of endogenous corticosteroids, thereby reducing
inflammation. The compound inhibits the enzyme
11-beta-hydroxysteroid dehydrogenase type 2 (11β-HSD2), which is responsible for the conversion of active
cortisol to its inactive form,
cortisone. By inhibiting this enzyme, diammonium glycyrrhizinate effectively increases the levels of cortisol, which subsequently enhances its anti-inflammatory action.
Additionally, diammonium glycyrrhizinate modulates the activity of
nuclear factor-kappa B (NF-κB), a key transcription factor involved in the inflammatory response. NF-κB controls the expression of various pro-inflammatory cytokines and adhesion molecules. By inhibiting NF-κB activation, diammonium glycyrrhizinate reduces the production of these inflammatory mediators, thereby diminishing the overall inflammatory response.
Apart from its anti-inflammatory effects, diammonium glycyrrhizinate also exhibits potent antiviral properties. It interferes with the replication of certain viruses, such as the
hepatitis B virus (HBV) and the
hepatitis C virus (HCV). The compound disrupts the viral life cycle by hindering the assembly and release of viral particles, thereby limiting the spread of the virus within the host.
Moreover, diammonium glycyrrhizinate has demonstrated hepatoprotective effects, making it beneficial in the treatment of
liver diseases. It achieves this by stabilizing the hepatocyte membrane and preventing the leakage of liver enzymes. Additionally, it promotes the regeneration of liver cells and enhances the antioxidant capacity of the liver. This dual action helps to mitigate liver damage and promote hepatic recovery.
The antioxidant properties of diammonium glycyrrhizinate are attributed to its ability to scavenge free radicals and inhibit lipid peroxidation. By neutralizing reactive oxygen species (ROS), the compound protects cellular components from oxidative damage. This antioxidative action further complements its hepatoprotective effects and contributes to its overall therapeutic efficacy.
In summary, diammonium glycyrrhizinate exerts its therapeutic effects through multiple mechanisms. Its ability to modulate glucocorticoid receptor activity, inhibit NF-κB activation, interfere with viral replication, and protect liver cells underscores its versatility as a pharmacological agent. By understanding these mechanisms, researchers and clinicians can better appreciate the potential applications of diammonium glycyrrhizinate in the treatment of various inflammatory, viral, and hepatic conditions.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


